- Home
- SEVN vs PROF Comparison
SEVN vs PROF Comparison
Compare SEVN & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEVN
- PROF
- Stock Information
- Founded
- SEVN 1986
- PROF N/A
- Country
- SEVN United States
- PROF Canada
- Employees
- SEVN N/A
- PROF N/A
- Industry
- SEVN Real Estate Investment Trusts
- PROF Medical/Dental Instruments
- Sector
- SEVN Real Estate
- PROF Health Care
- Exchange
- SEVN Nasdaq
- PROF Nasdaq
- Market Cap
- SEVN 149.0M
- PROF 130.4M
- IPO Year
- SEVN N/A
- PROF N/A
- Fundamental
- Price
- SEVN $9.80
- PROF $6.20
- Analyst Decision
- SEVN Strong Buy
- PROF Strong Buy
- Analyst Count
- SEVN 2
- PROF 1
- Target Price
- SEVN $13.50
- PROF $11.00
- AVG Volume (30 Days)
- SEVN 62.1K
- PROF 81.2K
- Earning Date
- SEVN 10-27-2025
- PROF 11-13-2025
- Dividend Yield
- SEVN 11.32%
- PROF N/A
- EPS Growth
- SEVN N/A
- PROF N/A
- EPS
- SEVN 1.04
- PROF N/A
- Revenue
- SEVN $27,061,000.00
- PROF $11,840,000.00
- Revenue This Year
- SEVN N/A
- PROF $60.07
- Revenue Next Year
- SEVN N/A
- PROF $121.80
- P/E Ratio
- SEVN $9.53
- PROF N/A
- Revenue Growth
- SEVN N/A
- PROF 59.81
- 52 Week Low
- SEVN $9.84
- PROF $3.76
- 52 Week High
- SEVN $14.10
- PROF $9.17
- Technical
- Relative Strength Index (RSI)
- SEVN 38.37
- PROF 62.04
- Support Level
- SEVN $9.84
- PROF $5.21
- Resistance Level
- SEVN $10.90
- PROF $6.23
- Average True Range (ATR)
- SEVN 0.25
- PROF 0.37
- MACD
- SEVN -0.02
- PROF -0.00
- Stochastic Oscillator
- SEVN 8.49
- PROF 78.17
About SEVN Seven Hills Realty Trust
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.